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The human receptor forthe complement cleavage fragments C3b and C4b (comple-
ment receptor type 1, CRl) is found on the surfaces of erythrocytes, most peripheral
blood leukocytes, glomerular podocytes, and follicular dendritic cells, and in plasma
(1-3) . Besides the removal ofC3b- or C4b-coated microorganisms orimmune com-
plexes (4), CRl also serves as an inhibitor of the C3 and the C5 convertases by dis-
sociating C2b and Bb fragments and by acting as a cofactor for the factor I-medi-
ated cleavage of C3b and C4b (5, 6) . This regulatory capacity is shared by the
structurally related members ofa supergene family, termed the regulatorofcomple-
ment activation (RCA)t region, located on chromosome 1 (7-13) .
HumanCRl is a single chain glycoprotein with four allotypic variants that differ
inM r on SDS-PAGE by increments of40-50 kD (14-17) . The two most common
variants are termed F and S (orA and B allotypes) and exhibitM r of 250 and 290
kD, respectively. These variations reflect differing lengths of the polypeptides and
not posttranslational modifications, since distinct unglycosylated precursors have been
described (18) and incremental differences of 1.3 to 1.5 kb were also observed in the
CRl transcripts from various allotypes (19, 20) . ThecDNA that encodes the entire
F allotype of 2,039 amino acids (aa) has been sequenced and the extracellular por-
tion of the molecule is found to comprise 30 short consensus repeats (SCR). A fea-
ture that distinguishesCR1 from the other proteins of this gene family is the organi-
zation of the NH2-terminal 28 SCRs into four tandem long homologous repeats
(LHR) ofabout 450 aa, each containing seven SCRs . Extensive sequence homolo-
gies of 60 to 99% have been observed among the LHRs, suggesting that they have
arisen by gene duplication (21, 22).
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The genetic mechanisms that led to the generation of the allotypic forms of CRl
were initially explored by the analyses of the RFLP of the DNA from donors ex-
pressing the F or the S allotypes (19) . The evidence against the generation of the
differently sized allotypes by alternative splicing of the transcripts are threefold. First,
the appearance of additional Bam HI and Sac I fragments were associated with the
S allotype without the corresponding loss of any fragments in the DNA of homozy-
gous FF donors, indicatingthat insertion or deletion events, rather than mechanisms
involving single base changes, were responsible for these RFLPs. Second, introns
were duplicated in the F allele and an additional duplication was present in the S
allele. Third, the allotypic differences of 40-50 kD at the protein level and 1.4 kb
at the transcriptional level corresponded to the length of one LHR, suggesting that
addition or deletion of this unit formed the basis of the structural polymorphism
in human CRI (19) .
A quantitative polymorphism has also been observed in CRl in which the number
of receptors on erythrocytes was determined by an autosomal codominant mode of
inheritance (23-26). High or low CRl expression on erythrocytes was associated
with allelic 7 .4- and 6.9-kb genomic Hind III fragments, respectively (25, 26). Linkage
dysequilibrium was observed between this RFLP and the CR1 structural allotypes,
suggesting that this polymorphism was located within or near the CRI gene (19,
24, 25). The present study examines the molecular bases of these structural and
genomic polymorphisms by mapping the CRI gene and localizing the restriction
sites that determine these RFLPs.
Materials and Methods
GenomicLibraries.
￿
Large fragments ofthe DNA from peripheral bloodleukocytes or EBV
transformed cell lines of selected donors were obtained by partial digestion with Sau 3A I
and selection on a 10-407o sucrose gradient. The fractions containing DNA of 35-45 kb were
pooled, precipitated in ethanol, and ligated to the cosmid vectors pjB8 or pNNRI (27). The
plasmid pNNRI was derived form pTCF (28) by substitution of the Hpa I site by a Not I
site. For the construction of genomic libraries in phage, the DNA fragments of 18-25kb from
the sucrose gradient were ligated to EMBL-3 arms (29) (Stratagene, San Diego, CA) and
the recombinant clones were amplified on Escherichia coli strain P2392 . The genomic library
in EMBL-3 of a donor who expressed the S allotype of CRI was the gift of Dr. John H.
Weis (Harvard Medical School, Boston, MA) (21). Recombinant CRI clones were identified
by hybridization to '2P-labeled cDNA probes.
Southern BlotAnalysis and Mapping ofRecombinant Clones.
￿
DNA was isolated from peripheral
blood leukocytes or EBVtransformed cell lines and analyzed after digestion with restriction
enzymes and agarose gel electrophoresih as previously described (19). The DNA from the
transformed cell lineswas compared on Southern blots to DNA isolated from the peripheral
blood leukocytes ofthe same donor to ascertain that rearrangement had not occurred. Recom-
binant phage or cosmid DNA was isolated by centrifugation on CsCl gradients (27) and ana-
lyzed by probing the blots of the restriction digests with cDNA or genomic fragments. The
order of the restriction sites was determined by probing the blots of the partial digests with
DNA fragments derived from the left or right arm of phage X, termed MAP-L and MAP-R,
respectively (30). The restriction maps of the cosmid clones were similarly determined by
analysis of Not I-linearized DNA using probes specific for the fragments to the right or to
the left of the Hpa I/Not I site.
Probes.
￿
Restriction fragments ofCRI cDNA (Fig. 1 A) were subcloned into PUC18. Owing
to the high sequence homology among the LHRs, crosshybridization is observed (Table I).
Thus, although CR1-1 is derived from LHRB, it hybridizes to corresponding regions in
LHRA, -C, and -D. CRl-4 hybridizes to the first two SCRs in LHRB and -C, while CRI-18x
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TABLE I
Patterns of Hybridization of CR1 cDNA Probes
and CRl-19 are specific for the 5' region of LHR-A and CRI-10 for the 5' region of LHRD
(21, 22). CRI-12 represents a segment of an intron between SCR-8 and -9 (21).
The intervening sequence probes, GBIR1, GB1HE (HE), GB2PE (PE), GB2PX (PX),
and GB2SS (SS) were derived from the two distinct polymorphic Bam HI fragments that
had been cloned from selected donors (19) (Fig. 1 B). The insert from clone 16.1 is associated
exclusively with the expression of the S allotype and is expected to lie within the structural
gene ofCRI (19). GB2PE, -PX, and -SS are Pvu II-Bam HI, Pvu II-Xba I and Ssp I frag-
ments of-400, -800, and -300 bp, respectively. GBIR1 and -HE are Eco RI and Hind III-
Barn HI fragments of 1.85 kb and -400 bp, respectively. Probe 2.22.2, derived from the 3'
end of phage clone 2 .22, is located in a 15-kb intron in LHRD. None of the genomic probes
contained CRI-specific coding sequences of human repeat sequences.
DNA Sequence Analysis.
￿
Restriction fragments of genomic clones were subcloned into
M13mp18 or M13mp19 and sequenced by the dideoxynucleotide chain termination method
(31) using a Sequenase Kit (U. S. Biochemical, Cleveland, OH) (32). DNA sequence analyses
were performed at the computer facility ofthe Howard Hughes Medical Institute, Harvard
Medical School Department of Genetics, using the Genetics Computer Group software of
the University of Wisconsin Biotechnology Center (33).
Results
The Organization ofthe SAllele ofCRI.
￿
The analysis of the structure and polymor-
phisms of the human CR1 gene was performed by restriction mapping of phage
and cosmid clones identified by a series of cDNA probes spanning the CRI gene
(Fig. 1 A). When large spans of intervening sequences occurred, genomic libraries
were screened with derived genomic probes, e.g., 2 .22 .2 . Few cosmid clones contain-
ing inserts corresponding to the homologous regions within the CRI structural gene
were identified, perhaps reflecting a high frequency ofrecombination leading to the
loss of such clones. Restriction mapping of the genomic clones was performed with
four enzymes that identified genomic polymorphisms, Bam HI, Eco RI, Hind III,
and Sac I .
The alignment of 25 overlapping phage and cosmid clones permitted the map-
ping of 160 kb that contained all of the S allele. The gene can be divided into nine
regions: the 5' region containing untranslated and leader sequences; five regions having
exons encoding the LHRs; a short region containing the two 3' SCRs that are not
included within an LHR; a segment having exons encoding the transmembrane and
cytoplasmic regions; and 3' untranslated sequences (Fig. 2). Sequence analysis of
the 5' genomic clone revealed a single exon encoding the signal peptide and part
of the 5' untranslated sequences. The 3' boundary of this exon was located at the
SCR
LHR-A
Probe SCR
LHR-B
Probe SCR
LHR-C
Probe SCR
LHR-D
Probe
1 CRI-18 8 CRI-4 15 CRI-4 22 CRI-10
2 CRI-19 9 CRI-4 16 CRI-4 23 CRI-10
3 CRI-2 10 CRI-2 17 CRI-2 24 CRI-5A
4 CRI-1,1-2 11 CRI-1,1-2 18 CRI-1,1-2 25 CRI-5A
5 CR1-1,1-2 12 CR1-1,1-2 19 CRI-1,1-2 26 CRI-1,1-2
6 CRI-1,1-2 13 CRI-1,1-2 20 CR1-1,1-2 27 CR1-1,1-2
7 CRI-1 14 CRIA 21 CR1-1,1-2 28 CRI-1,1-2S ALLELE
WONG ET AL.
￿
851
5'UT LS
￿
LHR-A
￿
LHR-B/A
￿
LHR-B
￿
LHR-C
￿
LHR-D
￿
3'SCR: TM/CY
￿
3' UT
1
￿
1
￿
1
￿
I
￿
1
￿
I 1
￿
1
F ALLELE
LHR-A LHR-B LHR-C
1 1 1
10 kb
FIGURE 2.
￿
The S and F alleles of human CRl. The heavy black bars represent the genes and
the lines underneath each represent the overlapping phage or cosmid clones that were aligned
to obtain the restriction maps. The vertical marks divide the functional domains ofthe genewhich
are designated as in Fig. 1 A.
glycineresidue at position 41 (Fig. 3) which is predicted to be thesite forthe cleavage
of the signal peptide (22). At the 3' end of the gene, separate exons encode the last
two SCRs as demonstrated by the hybridization of CRl-8 and 1-11 to two distinct
Nsi I fragments and the absence of a Nsi I site in the cDNA (Fig. 4 and reference
21). Therest of the 3' coding sequence is contained within threeexons, one encoding
residues 1969-1976 and the others containing the transmembrane and cytoplasmic
domains. The 3' untranslated sequences detected by CR1-15 are located N9 kb fur-
ther downstream (Fig. 4).
Between these 5' and 3' genomic regions were the five segments ranging in length
from 18 to 30 kb that hybridized to cDNA probes specific for LHRA, -B, -C, and
-D (Figs. 2 and 4). The designationof the genomic segments according to the LHRs
uses the nomenclature previously used for the cDNA sequences of the F allotype
(21, 22). Despite the high level of similarities between cDNA sequences of different
LHRs that resulted in crosshybridization of certain probes under stringent condi-
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FIGURE 3.
￿
Nucleotide and derived amino acid sequences from genomic clone 5.2 showing the
intron/exonjunction following the leader sequence. Residues -1 to -27 ofthe 5' untranslated se-
quence are identical to those found in the cDNA clone T109.4 (22). The arrow designates the
proposed splice site followed by the consensus 3' splice sequence.852
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￿
Restriction map of theS allele of CRl . The black bars represent contiguous regions
ofthe gene and the white and stippled boxes are the regions to which thecDNA and the genomic
probes hybridized, respectively. The placement of the probes on the mapwasdetermined by re-
striction mapping, Southern blot analyses and comparison of these restriction sites to those in
the cDNA sequence (21, 22) . Some of these placements were approximated and sequence anal-
yses have not been performed in all cases to determine the exact intron/exon boundaries. The
bracket over the 5' end ofLHRB/A designates the 2.7-kb gap to which no phage clones could
be unambiguously assigned . The restriction sites are designated as follows : A, Ava 1 ; B, Barn
HI, H, Hind III; L, Sal I; R, Eco RI, and S, Sac I . Not all Ava I sites are shown . The Hind
III site markedwith an asterisk in LHRD corresponds to the polymorphic site described in Figs .
7 and 8 .
tions, each LHR genomic region could be distinguished either because of unique
hybridizations with cDNA probes or because of distinct restriction maps (Fig . 4) .
TheLHRA genomicregion was identified by its unique hybridization with the CR1-18
and CRl-19 probes, whereas recognition of the LHRB and -C genomic segments
was possible because their 3' regions differentially hybridized with the intervening
sequence probes PX, SS, and HE . The LHRD region could be distinguished by
its hybridization with CR1-10 and CR1-5A .
The genomic region present between the LHRA and -B segments contained a
14.5-kb Bam HI fragment and a 19-kb Sac I fragment that were previously found
to be associated with expression of the S allotype, This region most resembled a
hybrid comprising the 5' half of the LHRB segment, which can be distinguished
from this region of the LHR-C segment by the Ava I site (Fig. 4), and the 3' half
oftheLHRA segment and is thereforetermed LHRB/A . It is considered to contain
exons encoding the fifth LHR that had been postulated to be present in the S allo-
type (19) . At the 5' end of theLHRB/A genomic segment, there is an apparent gap
of2 .7 kb to which no phage clones couldbe assigned . However, when Southern blots
containing the Barn HI, Eco RI, Hind III, and Sac I digests ofDNA from individ-
ualshomozygous or heterozygous fortheF andS allotypeswere probed withCRl-4
and PE, identical patterns were observed for the relevant junction regions (Fig . 5) .WONG ET AL .
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FIGURE 5 .
￿
Autoradiographs of the Southern blots in which CRI-4 and GB2PE were hybridized
to the restriction digests of the DNA from donors expressing the different structural allotypes
ofCRI . A Hind III digest oftheXDNA wasused as a marker and the positions ofthese fragments
are designated in kilobases on theleft. The fragments derived from thejunctions ofLHRsegments
in the structural gene are designated by arrows on the right . Additional hybridizing bands were
derived from the nonoverlapping cluster described in Fig. 9 .
Therefore, the restriction fragments spanning the junctions between the segments
ofLHRA and -B, LHR-A, and -B/A, and LHR-B/A and -B were identical in size
(Figs . 4 and 6), suggesting that the 2.7-kb gap exists in our map only because of
an inability to make a unique assignment of a genomic clone to this region .
Comparison of the LHR segments of the CRI gene revealed several remarkable
similarities . For example, the PE genomic probe from the 5' region of theLHRB/A
segment crosshybridized under stringent conditions to the corresponding regions
of the LHR-B and -C genomic segments (Fig . 4) and each site of hybridization was
flanked by a series of nine identical restriction sites (Fig. 4). Similarly, the 3' regions
ofLHRA and -B crosshybridized with genomic probes from the 3' region of the
LHR-B/A segment and these regions also contained similar restriction sites .
In contrast to these highly homologous regions of theCRl gene were unique seg-
ments that included the 5' portion of LHR-A, the 3' portion ofLHR-C, and all of
LHRD (Fig. 4) . Although the intervening sequence probe GBIR1 hybridized to
the 5' introns in both the LHR-A and -D segments, these regions did not have a
similar relationship to flanking exons . The intron recognized by this probe in the
LHR-A segment wasbetween exons encoding SCR-2 and -3, whereas in theLHR-D
segment, the intron was 5' to the exons encoding the first two SCRs of this LHR
(Fig . 4) . Differences could be found even in genomic segments containing exons
having almost identical sequences . Forexample, although SCR-3 through -7 ofLHRA
were 98% identical in nucleotide sequence to SCR-10 through-14ofLHR-B, the lat-854
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ter could be distinguished at the genomic level by additional Bam HI and Hind III
sites and the hybridization of the SS and HE genomic probes to smaller 1.8-kb
Hind III and 1.5 kb Eco RI fragments, respectively (Fig. 4). These differences high-
light the similarities between the LHRB/A genomic segment and the homologous
regions ofthe LHRA and -B segments andstrongly suggestthat the coding sequences
of LHR-B/A will be similar respectively to LHR-B and -A (Fig. 4).
The intron/exon organization of the five homologous segments of the CR1 gene
could be inferred from the restriction mapandthepatternofhybridizationofcDNF
probes. In the LHR-A region, the hybridization ofcDNA probes specific for SCR:
and -2 to three distinct Bam HI fragments (Fig. 4) and the finding of noncoding
sequences between the codons for residues 134 and 135 of SCR-2 (Bartow, T. J.,
unpublished observations) indicate that SCR-2 isencoded by atleast two exons. Simi-
larly, CRI-4, a 381-bp cDNA probe encoding SCR15 and SCR-16 of LHRC that
is highly homologous to the corresponding two SCRs ofLHR-B/A and -B, hybrid-
ized to three Hind III fragments of7.3, 2.2, and 1.8 kb on Southern blots ofDNA
from individuals having the FF, FS, and SS allotypes (Fig. 5). As therestriction maps
ofthese respective regions of the CR1 gene were identical (Fig. 4) and there were
no Hind III sites within CRI-4, the occurrence ofthree hybridizingfragments indi-
cates that at least three exons encode each pair of NH2-terminal SCRs of these
LHRs. Furthermore, CRI-12 is a cDNA probe derived from unspliced intervening
sequence between residues 551 and552 ofSCR-8 and -9, respectively (21). It hybrid-
ized to the 1.8-kb Hind III fragment from each LHR region, suggesting that the
first SCR ofeach LHR is probably encoded by a single exon. The second SCR of
LHR-B/A, -B, and LHR-C must be encoded by at least two exons separated by the
intervening sequence identified by the probe, PE (Fig. 4). In LHR-D, intervening
sequences have been foundbetween three distinct regions that hybridized toCR1-10,
the cDNA probe encoding the NH2-terminal two SCRs ofLHR-D (Figs. 4 and 8).
Thus, the second SCR of each LHR is encoded by at least two exons.
The Eco RI-Hind III fragment of-250 bp, whichwas conserved among LHRs-A,
-B/A, -B, and -C, may contain the third and fourth SCRs since both enzyme sites
were present in the cDNA and no hybridization to CR1 or CRI-2 was observed in
the DNA fragments that were 5' ofthis region in each LHR. Thus, these two SCRs
are encoded either by a single exon or by two exons separated by a small intron.
The locationoftheinterveningsequence probes among regions ofcDNAhybridiza-
tionindicates that at leastfour exons encode thethird to theseventh SCR ofLHR-A,
-B/A, and -B. Similarly, in LHRC and -D, the CR1-1 and CRl-2 probes hybridized
to four distinct fragments (Fig. 4), and sequence analysis showed that the seventh
SCR in LHR-C was contained within one exon (21). Thus, at least seven exons are
in each LHR, andcombiningthese with atleasttwo exons encodingthe two -COOH-
terminal SCRs not contained within an LHR (Fig. 4), adds up to at least 37 exons
encoding the ecto-domain of the S allotype of CRI.
The Organization ofthe FAllele ofCR1.
￿
To obtain further evidence that the F allo-
type ofCRI, which contains four LHRs, is not the product of alternative splicing
of a transcript encoding five LHRs, genomic segments ofthe three 5' LHRs ofan
F allele were mapped by aligning genomic clones from a library constructed with
DNA from an FF individual. The hybrization ofGBIR1 in the most 5' clones local-
ized the LHR-A genomic region and the restriction sites in this region correspond
to those of the LHRA segment of the S allele (Figs. 4 and 6). Downstream ofthisWONG ET AL .
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FIGURE 6 .
￿
Partial restrictionmapofLHRA, -B, and -C ofthe F allele. The black bars represent
contiguous segments of the gene while the white and stippled boxes are the regions to which
the cDNA andthegenomic probes hybridized, respectively . The restriction sites are designated
as in Fig . 4 .
region was a segment distinguished by Hind III and Eco RI restriction fragments
of 1.8 and 1 .5 kb, respectively, that hybridized to the genomic probes, SS and HE,
making this region identical to the LHR-B rather than the LHRB/A region of the
S allele. Thethirdhomologous region was identical to theLHRC segment andlacked
hybridization to the intervening sequence probes, PX, SS, andHE (Figs. 4 and 6) .
Although the LHRD region was not included in the clones analyzed, its presence
in the F allele is demonstrated by the cDNA sequence (21) and from analysis by
Southern blots ofDNA from FF homozygotes . In summary, the F allele does not
contain the LHR-B/A genomic region of the S allele, indicating that its primary
transcript contains four rather than five LHRs .
Definition oftheHindIIIPolymorphism Associated with the CRI Quantitative Polymorphism.
The allelic Hind III fragments of 7.4 and 6.9 kb that correlated with high and low
expression, respectively, ofCR1 on erythrocytes were localized to theLHRD genomic
region by their hybridization to the CR1-10 cDNA probe (Fig . 7) . In this Southern
FIGURE 7 .
￿
Autoradiograph of the South-
ern blot in which CRI-10 was hybridized
to the Hind III and/or Kpn I digests of
theDNAofdonors expressing high (HH),
intermediate (HL), or low(LL) numbers
ofCRI on their erythrocytes. A Hind III
digest of ofXDNA was used as a marker
and the positions of these fragments are
designated in kilobases on the left . The
fragments derived from the structural gene
are designated by arrows on the right .
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blot, a fragment of2.35 kbhybridizing to 1-10wasobserved that has not been found
in any CRI genomic clones. Restriction maps of two allelic genomic clones, 2.22
and 2.38, that hybridized with CRI-10 revealed that although they contained iden-
tical 3.5-kb Kpn I fragments, double digestion with Kpn I and Hind III generated
distinct fragments of 3.0 and 3.5 kb, respectively (Figs. 7 and 8). The additional
Hind III site in 2.22 accounting for the smaller fragment was0.5 kb upstream from
the 3' Hind III site ofthe 7.4-kb restriction fragment in clone 2.38, and therefore
corresponded to the site responsible for the 6.9-kb Hind III fragment defining the
L allele. Sequence analysisof 126-bp Eco RV to Rsa I fragments from both genomic
clones identified the single base change responsible for the additional Hind III site
in 2.22 relative to 2.38 and confirmed its location in noncoding sequences of the
gene (Fig. 8).
Duplication ofthe CRI Gene.
￿
Evidenceforduplication oftheCR1 gene wasprovided
by the finding of a cluster ofoverlapping phage clones spanning 60 kb that hybrid-
ized at high stringency to CRl cDNA and genomic probes (Fig. 9). The first 36
kb ofthiscluster contained regions homologous to the signal peptide and the SCRs
ofLHR-A. Hybridization to the noncoding probes, GBIR1, PX, SS, and HE were
also observed in the same 5' to 3' order as in the LHRA genomic segment. The
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Restriction maps, sequence strategy and partial sequence oftheinsertsofthephage
clones 2.38 and 2.22 whichcontain the allelic 7.4- and 6.9-kb Hind III fragments that are as-
sociated with the high (H) or low (L) expression of CR1, respectively. The restriction sites are
as follows: A, Rsa I; B, Barn HI; G, Bgl I; H, Hind III; K, Kpn I; R, Eco RI; S, Sac I and
V, Eco RV. The polymorphic Hind III site is designated in italics with an asterisk and the Hind
III sites that flank the 7.4- and 6.9-kbfragments are in boldface. The brackets above the clones
represent the regions which hybridizeto the CRI-10 probe. Thebases correspondingto the new
Hind III site are enclosed in a box.
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(A) Restriction map of theCRl-like nonoverlapping cluster of genomic clones. The
blackbars represent thegene andthewhite andstippled boxesarethe regions to whichthe cDNA
and the genomic probes hybridized, respectively. The restriction sites are designated as in Fig.
4. The polymorphic sites are designated with asterisks. (B) The heavy line represents the gene
and the lighterlines represent the overlapping phage or cosmid clones used to generate the re-
striction map in (A).
3' portion of this segment of DNA resembled the LHR-C more than the LHR-B
region in its capacity to hybridize to the CRl-4, 1-12, PE, and 1-1 probes and its
lack ofhybridization to the PX, SS, and HE probes. However, the restriction map
forthese clones was clearly distinct from that for the CRI structural gene, indicating
that this is a duplicated and not allelic region (Fig. 9).
￿
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Three polymorphic sites that accounted for previously identified genomic poly-
morphismshave beenmapped to this region. Theabsenceorpresence ofan Eco RI
site located 16 kb from the 3' end ofthis cluster determines the allelic 20- and 16-kb
Eco RI fragments hybridizingwith CR1-1 and CR1-4 thathave been found in DNA
from all 85 individuals that have been examined (19). The absence of a Barn HI
site 28 kb from the 5'endofthis second clusterdetermines the appearance ofa 14.5-kb
Bam HI fragment hybridizing with GBIR1 that corresponds to the insert ofclone
4.2 (see Materials and Methods) in N10% ofnormal individuals (19). This Barn HI
polymorphism isassociated with thepresence ofan additional SacIsite 3.5 kb down-
stream that accounts forthe appearance of7.9- and 3.3-kb fragments thathybridize
with CRl-4 and CR1-1, respectively (19). Whether these polymorphisms have any
effects on CR1 expression remains unknown since linkage dysequilibrium has not
been observed with the structural or quantitative polymorphisms (19).
Discussion
The S allele ofhuman CRI contained five LHR segments of 20 to 30 kb each,
while the cDNA and a partial genomic map of the F allele showed that there were858
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only four homologous regions(Figs. 1, 2, 4, and6). The longer transcripts associated
with the S allotype were products of this longer allele with coding capacity for an
additional seven SCRs or -450 aa. Although sequence homology existed in both
the coding and noncoding regions, each LHR segment had unique restriction sites
or introns. The association of the 14.5-kb Barn HI and the 19-kb Sac I fragments
with theLHRB/A segmentidentified this as theadditional DNAin theS allele (Figs.
4 and 6). The similarity ofthis segment to the 5' halfofthe LHR-B and the 3' half
o£ the LHRA segments predicts that its coding sequence will be identical to that
of LHRB. As LHRB and -C have recently been shown to contain C3b-binding
sites (22), the S allotype of CRI may have a third binding site for this ligand.
In the CRI gene, thesignal peptide, and the transmembrane and cytoplasmic regions
are encodedby separate exons, while most ofthe SCRs are found in exons of-200
by as has been reported in human C4BP, C2, factor B and IL-2R (Tac-I) and in
murine factor H (34-37). That the second SCR in each LHR is encoded by two
exons is an indication ofspecialized functional capacities ofthis repeat unit. Recent
evidence from the analyses ofthe C3b/C4b binding capacities ofCRl deletion mu-
tants lacking one or more LHRs indicated that the specificity for these ligands is
determined by the first two SCRs in each LHR (22). These observations are consis-
tent with the second SCR in murine factor Hbeing encoded by two exons and the
localization ofthe C3b binding site ofhuman factor H to the NH2 terminus ofthis
molecule (37, 38).
Within the CRl gene, the regionsofhomology ordivergence atthe genomic level
corresponded to those found in the cDNA, suggesting that each LHR evolved as
a 20-30-kb genomic unit. For example, as in the cDNA, the genomic regions that
contain the first two SCRs of LHR-B and -C were almost identical (Figs. 1, 4, and
6). Thus, the divergence ofLHR-A in the first two SCRs and their flanking introns
presumably reflects its preference for the ligand C4b over C3b (22). Conservation
of the third and fourth SCRs in LHRA, -B/A, -B, and -C was observed at both
the cDNA and the genomic, level, indicating a contribution of these units either to
the functional capacities oftheir neighboring SCRsorto othernecessities for struc-
tural constraints. In contrast to the similarities in both introns and exons between
the LHRA and -B segments, onlythe preservation ofcoding sequences wasobserved
in the LHR-C and -D genomic segments (Fig. 4 and reference 21).
The extended internal homologies observed in the elongated structure of CRl
provide opportunities for homologous recombination between two alleles in which
the generation ofthe different allotypes ofCR1 can be achieved by the addition or
deletion of one or more LHRs. For example, acquisition of LHRB/A as a hybrid
ofthe 5' halfof LHRB and the 3' halfofLHR-A can be achieved by a single cross-
over at the midpoints ofLHR-A and -B between two F alleles. The reciprocal result
of such an event might be an allele that lacks the 3' portion of LHRA and the 5'
portion of LHRB and contains only one C3b binding site (Fig. 10). The F' or C
allotype that is -40 kD smaller than the F allotype may be this reciprocal product
oftherecombination eventthat generated the S allotype. The presumed monovalency
forC3b ofthe F' allotype might impair binding ofC3b-bearing immune complexes,
accounting for the association of this allotype with systemic lupus erythematosus
(16, 39). A single crossover at the midpoints ofLHRA and -C of two F alleles can
also account foran allele whichcontains six LHRs (17) andperhaps four C3bbindingn
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FIGURE 10.
￿
Proposed scheme for the generation of the CR1 allotypes. The ancestral gene pre-
sumably containedasignal peptide (L), three LHRsegments, atransmembrane (T)and a cyto-
plasmicdomain (C), designated by separate boxes. Thedifferent patterns in theLHRs represent
regions ofdivergence. Thedouble arrows designatethe points ofcrossover andthebrackets under
the Tend of LHRA and the Tend of LHRC or -B represent the segments of DNA that have
been duplicated to generate the F and the S alleles, respectively.
sites. Similarly, the presentation ofLHRB as a hybrid ofthe 5' halfof LHRC and
the 3' halfof LHRA at both the cDNA and the genomic level suggests that it can
also be acquired by a similar crossover between two F allele precursors containing
three LHRs(Fig. 10). An alternatemechanism for theinsertion ofan LHR involves
direct duplication, and conversion events are necessary to maintain the high ho-
mology amongbothintrons and exons. Theseduplicationswithin CR1 maybedriven
by the combined necessity to extend the ligand binding sites awayfrom the cell sur-
face and the requirement to achieve increased avidity for C3b/C4b-coated surfaces
through multivalent interactions.
Duplicative events were probably responsible for the generation of functionally
andstructurally related geneswithin the RCA region (7-11). The findingofan addi-
tional cluster ofclones with CR1 related sequences provides further evidence for
CR1 duplication (Fig. 9). The close proximity of this second cluster ofclones has
been inferred from pedigree analyses in which the the Eco RI polymorphism which
mapped to the second gene was found to be linked to the structural polymorphism
ofCR1 (19). Furthermore, in the analyses ofthe RCA region by pulse-field electro-
phoresis, hybridization to repetitive or 5' and 3' CR1 cDNA probes was observed
within a single restriction fragment of -250 kb (12, 13).860
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An estimation ofthe sequences which are homologous to the cDNA probes CR1-1
and CR1-4 indicates that the nonoverlapping cluster of clones contains coding ca-
pacity for two LHRs. However, when these probes were used in Northern blot anal-
yses, no transcriptional products other than those relating to CRl were identified
in tonsils, peripheral blood leukocytes, and the myelomonocytic cell line, HL60, in-
dicating that the additional gene may not be transcriptionally active in hematopoi-
etic cells (19, 20, 40, 41). Furthermore, the finding of three genomic polymorphisms
within 16 kb of this cluster suggests that mutations may be occurring more frequently
relative to the structural gene. These clones may therefore represent a partial allele
generated during the multiple duplicative processes in the evolution of CRl or part
of a pre-CR1 gene having only LHR-A, -C, and -D, as depicted in Fig. 10. Evidence
in support of this hypothesis is the identification of an additional CR1-10-hybridizing
Hind III fragment of 2.35 kb that has not been localized to the structural gene (Fig.
7), suggesting that another segment similar to LHR-D may exist.
The Hind III polymorphism that was associated with the high or low expression
of CRl on erythrocytes was localized to a single base change in the intervening se-
quences between the exons encoding the second SCR in LHR-D. The occurrence
of this polymorphism 35 kb away from the 3' end of the LHR-B/A region accounts
for the lack of recombination between these genomic polymorphisms (19). Although
intragenic enhancer elements have been reported for the Ig genes, these regulatory
sequences are within several kilobases of the promoter region (reviewed in reference
42). Since the additional Hind III site is at least 70 kb away from the 5' promoter
region in an F allele, the effect ofthis base change on the expression ofCRl remains
unclear. However, the finding of individuals who were homozygous for the 7.4-kb
Hind III fragment associated with high expression of CRl but who consistently ex-
pressed low levels of CR1 (25) indicated that other genetic factors may be involved
and the Hind III site may represent a genetic marker for other cis factor(s) that regu-
late the expression of CRl.
Summary
Structural and quantitative polymorphisms have been described in human CRl.
In the former, the S allotype is larger than the F allotype by 40-50 kD, the size of
a long homologous repeat (LHR). In the latter, homozygotes for a 7.4-kb Hind III
fragment express fourfold more CRl per erythrocyte than do homozygotes for the
allelic 6.9-kb restriction fragment. The basis for these genomic polymorphisms has
been determined by restriction mapping the entire S allele and part of the F allele.
The S allele is 158 kb and contains 5 LHRs of 20-30 kb, designated -A, -B/A, -B,
-C, and -D, respectively, 5' to 3'. Extensive homology was found among the LHRs
in their restriction maps, exon organization, and the coding and noncoding sequences.
The presence of LHRB/A in the S allele but not in the F allele accounts for the
longer transcripts and polypeptide associated with the former allotype. At least 42
exons are present in the S allele, with distinct exons for the leader sequence, the
transmembrane and cytoplasmic regions and most of the SCRs comprising the ex-
tracellular portion of CR1 . Consistent with the mapping of the ligand binding site
to the first two SCRs in each LHR, the second SCRs in LHR-A, -B/A, -B, and -C
are encoded by two exons, reflecting a specialized function for this unit. The allelic
7 .4/6.9-kb Hind III fragments extend from the 3' region of LHR-C to LHRD. TheWONG ET AL.
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6.9-kb restriction fragment is the result of a new Hind III site generated by a single
base change in the intron between the exons encoding the second SCR of LHR-D.
A second cluster of genomic clones has been identified by hybridization to CRl probes.
Although they contain regions of hybridization to the cDNA and genomic probes
derived from CRl, these cannot be overlapped with the structural gene owing to
their distinct restriction maps. Three genomic polymorphisms previously identified
by CRl cDNA probes map to this region. These additional clones may represent
part of a duplicated allele located nearby within the CRl locus.
The authors would like to thank Dr. ThomasJ. Bartow for providing the nucleotide sequences
which detemined the 3' exon/intron junction within SCR-2 .
Receivedfor publication 18 August 1988 and in revisedform 17 November 1988.
References
1 . Fearon, D. T, and W. W. Wong. 1983 . Complement ligand-receptor interactions that
mediate biologic responses. Annu. Rev. Immunol. 1:243.
2 . Reynes, M., J. P. Aubert, J. H. M. Cohen, J. Audouin, V. Tricotet, J. Diebold, and
M. D. Kazatchkine. 1985. Human follicular cells express CRI, CR2, and CR3 comple-
ment receptor antigens. J Immunol. 135:2687.
3 . Yoon, S. H., and D. T. Fearon. 1985. Characterization ofa soluble form ofthe C3b/C4b
receptor (CR1) in human plasma. J. Immunol. 134:3332.
4. Cornacoff, J. B., L. A. Hebert, W. L. Smead, M. E. Van Aman, D. J . Birmingham,
and F. J. Waxman. 1983 . Primate erythrocyte-immune complex-clearing mechanism.
J Clin. Invest. 71:236.
5. Fearon, D. T 1979. Regulation of the amplification C3 convertase of human comple-
ment by an inhibitory protein isolated from human erythrocyte membrane. Proc. Natl.
Acad. Sci. USA. 76:5867 .
6. Iida, K., and V. Nussenzweig. 1981. Complement receptor is an inhibitor ofthe comple-
ment cascade. J Exp. Med. 153:1138.
7. Rodriguez de Cordoba, S., D. M. Lublin, P Rubinstein, andJ. P Atkinson. 1985. Human
genes for the three complement components that regulate the activation ofC3 are tightly
linked. J Exp. Med. 161:1189.
8. Weis, J. H., C. C. Morton, G. A. P Bruns, J. J. Weis, L. B. Klickstein, W. W. Wong,
and D. T Fearon. 1987, Definition of a complement receptor locus: the genes encoding
the C3b receptor and the C3d/Epstein-Barr virus receptor map to human chromosome
1.J Immunol. 138:312.
9. Rey-Campos,J., P. Rubinstein, and S. Rodriguez de Cordoba. 1987. Decay-accelerating
factor: genetic polymorphism and linkage to the RCA (regulator ofcomplement activa-
tion) gene cluster in humans. J Exp. Med. 166:246.
10. Lublin, D. M., R. S. Lemons, M. M. Le Beau, V. M. Holers, M. L. Tykocinski, M. E.
Medof, and J. P Atkinson. 1987. The gene encoding decay-accelerating factor (DAF)
is located in the complement-regulatory locus on the long arm of chromosome 1 .J Exp.
Med. 165:1731.
11 . Lublin, D. M., M. K. Liszewski, T. W Post, M. A. Arce, M. M. Le Beau, R. S. Lemons,
T. Seya, and J. P Atkinson. 1988. Molecularr cloning and chromosomal localization
of human complement membrane cofactor protein (MCP). J. Exp. Med. 168:181.
12 . Rey-Campos, J., P Rubinstein, and S. Rodriguez de Cordoba. 1988. A physical map
of the human regulator of complement activation gene cluster linking the complement
genes CRl, CR2, DAF and C4BP. J Exp. Med. 167:664.862
￿
STRUCTURE OF THE HUMAN CRI GENE
13. Carroll, M. C., E. M. Alicot, P. J. Katzman, L. B. Klickstein, J. A. Smith, and D. T.
Fearon. 1988. Organization of the genes encoding complement receptors type 1 and 2,
decay-accelerating factor, and C4-binding protein in the RCA locus on human chromo-
some 1. J. Exp. Med. 167:1271 .
14. Wong, W. W., J. G. Wilson, and D. R. Fearon. 1983 . Genetic regulation of a structural
polymorphism of human C3b receptor. J. Clin. Invest. 72 :685.
15. Dykman, T. R., J. L. Cole, K. Iida, and J. P. Atkinson. 1983. Polymorphism of human
erythrocyte C3b/C4b receptor. Proc. Natl. Acad. Sci. USA. 80:1698.
16. Dykman, T R., J. A . Hatch, and J. P. Atkinson. 1984. Polymorphism of the human
C3b/C4b receptor. Identification of a third allele and analysis of receptor phenotypes
in families and patients with systemic lupus erythematosus. f. Exp. Med. 159:691.
17 . Dykman, T. R., J. A. Hatch, M. S. Aqua, and J. P Atkinson. 1985. Polymorphism of
the C3b/C4b (CRI) receptor: characterization of a fourth allele. f. Immunol. 134:1787.
18. Lublin, D. M., R. C. Griffith, J . P Atkinson. 1986. Influence of glycosylation on allelic
and cell specific M, variation, receptor processing and ligand binding of the human com-
plement C3b/C4b receptor. .) Biol. Chem. 261:5736.
19. Wong, W. W., C. A. Kennedy, E. T. Bonaccio, J. G. Wilson, L. B. Klickstein, J. H.
Weis, and D. T Fearon. 1986. Analysis of multiple restriction fragment length polymor-
phisms of the gene for the human complement receptor type 1 . Duplication of genomic
sequences occurs in association with a high molecular mass receptor allotype. J. Exp.
Med. 164:1531.
20. Holers, V. M., D. D. Chaplin, J. R Leykam, B. A. Gruner, V. Kumar, and J. P At-
kinson. 1987 . Human CRl mRNA polymorphism correlates with the CRI allelic molec-
ular weight polymorphism. Proc. Natl. Acad. Sci. USA. 84:2459.
21 . Klickstein, L. B., W. W. Wong,J. A. Smith,J. H. Weis, J. G. Wilson, and D. T Fearon.
1987. Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating
domains that are composed of the short consensus repeats characteristic ofC3/C4 binding
proteins. J. Exp. Med. 165 :1095.
22 . Klickstein, L. B., T J . Bartow, V. Miletic, L. D. Rabson, J . A. Smith, and D. T Fearon.
1988. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b
receptor (CRI, CD35) by deletion mutagenesis. J. Exp. Med. 168:1699.
23 . Wilson, J. G., W. W. Wong, P. H. Schur, and D. T Fearon. 1982 . Mode of inheritance
of decreased C3b receptors on erythrocytes of patients with systemic lupus erythematosus.
N. Engl. J. Med. 307:981.
24 . Rodriguez de Cordoba, S., and P. Rubinstein. 1987. Quantitative variations of CRI in
human erythrocytes are controlled by genes within the RCA cluster. J Exp. Med. 164:1274.
25 . Wilson, J. G., E. E. Murphy, W. W. Wong, L. B. Klickstein, J. H. Weis, and D. T Fearon.
1986. Identification of a restriction fragment length polymorphism by a CRI cDNA that
correlates with the number of CRI on erythrocytes. J. Exp. Med. 164:50.
26 . Moldenhauer, F., J. David, A. H. L. Fielder, P J. Lachmann, and M. J. Walport. 1988.
Inherited deficiency of erythrocyte complement receptor type 1 does not cause suscepti-
bility to systemic lupus erythematosus. Arthritis Rheum. 30:961.
27 . Maniatis, T, E. F. Fritsch, and J. Sambrook. 1982 . Molecular Cloning: A Laboratory
Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. 545 pp.
28. Grosveld, F. G., T. Lund, E. J. Murray, A. L. Mellor, H. H. M. Dahl, and R. A. Flavell.
The construction of cosmid libraries which can be used to transform eukaryotic cells.
Nucleic Acids Res. 10:6715.
29 . Frischauf, A. M ., H. Lehrach, A. Poustka, and N. Murray. 1983. Lambda replacement
vectors carrying polylinker sequences. J. Mol. Biol. 170:827 .
30 . Rackwitz, H-R., G. Zehetner, A.-M. Frischauf, and H. Lehrach. 1984. Rapid restric-
tion mapping of DNA cloned in lambda phage vectors. Gene. 30:195.WONG ET AL.
￿
863
31 . Sanger, F, S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating
inhibitors. Proc. Nall. Acad. Sci. USA. 75:4853.
32. Tabor, S., and C. C. Richardson. 1987. DNA sequence analysis with a modified bacte-
riophage T7 DNA polymerase. Proc. Natl. Acad. Sci. USA. 84:4767.
33 . Devereux, J ., P. Haeberli, and O. Smithies. 1984. A comprehensive set ofsequence anal-
ysis programs for the VAX. Nucleic Acids Res. 12:387.
34. Lintin, S. J., A. Lewin, and K. B. M . Reid. 1988 . Studies on the structure of the human
C4b-binding protein gene and characterization of the protein signal sequence. Comple-
ment. 4:186. (Abstr.)
35 . Campbell, R. D., and D. R. Bentley. 1985. The structure and genetics of the C2 and
factor B genes. Immunol. Rev. 87 :19.
36. Leonard, W. J ., J. M. Depper, M . Kanehisa, M . Kronke, N. J. Peffer, P B. Svetlik,
M. Sullivan, and W C. Greene. 1985. Structure ofthe interleukin-2 receptor gene. Science
(Wash. DC). 230:633.
37 . Vik, D. P., J. B. Keeney, P Munoz-Canoves, D. D. Chaplin, and B. F. Tack. 1988. Struc-
ture of the murine complement factor H gene. J. Biol. Chem. 263:16720.
38. Alsenz, J., T. F. Schultz, J. D. Lambris, R. B. Sim, and M. P Dierich. 1985. Structural
and functional analysis of the complement factor H with the use of different enzymes
and monoclonal antibodies to factor H. Biochem. J. 232:841.
39. Van Dyne, S., V. M. Holers, D. M. Lublin, andJ. P. Atkinson. 1987 . The polymorphism
of the C3b/C4b receptor in the normal population and in patients with systemic lupus
erythematosus. Clin. Exp. Immunol. 68:570.
40. Wong, W. W., L. B. Klickstein, J. A. Smith, J. H. Weis, and D. T Fearon. 1985.
Identification ofa partial cDNA clone for the human receptor for complement fragments
C3b/C4b. Proc. Natl. Acad. Sci. USA. 82:7711 .
41 . Jack, R. M., and D. T Fearon. 1988. Selective synthesis ofmRNA and proteins by human
peripheral blood neutrophils. J Immunol. 140:4286.
42 . Gregor, P. D., B. J. Korbin, C. Milcarek, and S. L. Morrison. 1986. Sequences 3' of
immunoglobulin heavy chain genes influence their expression. Immunol. Rev. 89:32.